Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE
    • Publication Information:
      Original Publication: Oxford, Blackwell Scientific Publications.
    • Subject Terms:
      Biomarkers, Tumor/*metabolism ; Liposarcoma/*metabolism ; Repressor Proteins/*genetics ; STAT6 Transcription Factor/*genetics ; Solitary Fibrous Tumors/*metabolism; Cell Nucleus/metabolism ; DNA Copy Number Variations ; Gene Fusion ; Humans ; Immunohistochemistry ; Liposarcoma/genetics ; Liposarcoma/pathology ; Paraffin Embedding ; Repressor Proteins/metabolism ; STAT6 Transcription Factor/metabolism ; Solitary Fibrous Tumors/diagnosis ; Solitary Fibrous Tumors/genetics
    • Abstract:
      Aims: Nuclear relocation of STAT6 has been shown in tumours with NAB2-STAT6 fusion, and has been proposed as an ancillary marker for the diagnosis of solitary fibrous tumours (SFTs). The aim of this study was to verify the utility of STAT6 immunohistology in diagnosing SFT.
      Methods and Results: A total of 689 formalin-fixed paraffin-embedded tumours comprising 35 pleural SFTs and 654 other mesenchymal tumours were investigated for STAT6 expression using immunohistochemistry. Nine dedifferentiated liposarcomas (DDLSs) and five SFTs were also examined for the presence of NAB2-STAT6 fusion at the protein level using the proximity ligation assay (PLA), and for copy number variants (CNVs) with the Illumina Infinium Human Methylation450 array. Thirty-four of 35 SFTs showed strong nuclear STAT6 expression. Furthermore, five of 68 DDLSs, two of 130 undifferentiated pleomorphic sarcomas and one of 63 cases of nodular fasciitis showed moderate to strong nuclear STAT6 expression. The PLA indicated the presence of NAB2-STAT6 fusion protein in SFTs, but signal was also detected in some DDLSs. Copy number analysis showed an overall low frequency of chromosomal imbalances in SFTs, but complex karyotypes in DDLSs, including amplification of STAT6 and MDM2 loci.
      Conclusions: The detection of nuclear relocation of STAT6 with immunohistochemistry is a characteristic of SFTs, and may serve as a diagnostic marker that indicates NAB2-STAT6 fusion and helps to discriminate SFTs from histological mimics.
      (© 2014 John Wiley & Sons Ltd.)
    • Contributed Indexing:
      Keywords: NAB2; STAT6; amplification; fusion; liposarcoma; solitary fibrous tumour
    • Accession Number:
      0 (Biomarkers, Tumor)
      0 (NAB2 protein, human)
      0 (Repressor Proteins)
      0 (STAT6 Transcription Factor)
      0 (STAT6 protein, human)
    • Publication Date:
      Date Created: 20140408 Date Completed: 20170414 Latest Revision: 20230718
    • Publication Date:
      20240829
    • Accession Number:
      10.1111/his.12431
    • Accession Number:
      24702701